Globus Medical Inc (N:GMED)

Business Focus: Medical Equipment, Supplies & Distribution

Apr 16, 2024 04:30 pm ET
Globus Medical Schedules First Quarter Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, May 7, 2024. A copy of the release will be available on...
Feb 20, 2024 04:15 pm ET
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2023. Fourth Quarter 2023: Worldwide net sales were $616.5...
Feb 13, 2024 05:17 pm ET
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Tuesday, February 20, 2024. A copy of the...
Feb 09, 2024 03:15 am ET
CapitalGainsReport Sector Spotlight: Orthobiologics Watchlist (ORHB, ZBH, GMED, SYK)
Orthobiologics represents a dynamic field within healthcare where the body's natural healing mechanisms address osteoarthritis and enhance recovery from tendon and ligament injuries. These therapies signify a significant evolution in medical treatment, offering promising solutions for patients worldwide.
Feb 05, 2024 04:30 pm ET
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the promotion of Keith Pfeil as chief operating officer (COO) and chief financial officer (CFO). Having served as the Company’s CFO since August 2019,...
Jan 10, 2024 04:30 pm ET
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2023. The company anticipates fourth quarter 2023 sales of...
Dec 19, 2023 03:00 am ET
4 Orthobiologic Stocks Set To Soar In 2024
Welcome to the transformative landscape of orthobiologics, where cutting-edge treatments utilize the body's own cells and healing factors to reverse orthoarthritis effects and expedite recovery from tendon and ligament injuries. These innovations, naturally derived and featuring stem cells, represent a paradigm shift in healthcare.
Nov 07, 2023 04:15 pm ET
Globus Medical Reports Third Quarter 2023 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2023. The merger with NuVasive, Inc. was completed on September 1, 2023 and results presented...
Oct 24, 2023 04:30 pm ET
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2023 after the market close on Tuesday, November 7, 2023. A copy of the release will be...
Oct 24, 2023 07:00 am ET
Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, presented five-year outcomes from the NuVasive Simplify Cervical Disc study at the North American Spine Society (NASS) 38th Annual Meeting. The study demonstrates...
Oct 10, 2023 07:00 am ET
Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, celebrated twenty years of the NuVasive XLIF procedure at the Society for Minimally Invasive Spine Surgery (SMISS) ’23 Annual Forum. “Very few medical technology...
Sep 27, 2023 07:00 am ET
Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it will continue its partnership with EUROSPINE as a silver sponsor and will attend EUROSPINE 2023 held October 4 to 6 in Frankfurt. “As leaders in...
Sep 07, 2023 07:00 am ET
NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of NuVasive Specialized Orthopedics’ (NSO) Precice Bone Transport system in targeted regions. The latest addition to the less...
Sep 01, 2023 08:33 am ET
Globus Medical Completes Merger with NuVasive
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it has completed its previously announced merger with NuVasive, Inc. The combined company will provide surgeons and patients with one of the most...
Aug 03, 2023 04:30 pm ET
Globus Medical Reports Second Quarter 2023 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2023. Worldwide net sales were $291.6 million, an increase of 10.6%GAAP net income for the...
Jul 31, 2023 08:30 am ET
Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the MARVEL™ Growing Rod System, which is designed for pediatric patients with early onset scoliosis to obtain and maintain...
Jul 13, 2023 04:30 pm ET
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2023 after the market close on Thursday, August 3, 2023. A copy of the release will be...
May 15, 2023 04:30 pm ET
Globus Medical Announces FDA Approval for its Non-Fusion Scoliosis Correction System, the Latest Advancement for Young Patients with Idiopathic Scoliosis
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the REFLECT™ Scoliosis Correction System has been granted approval from the US Food and Drug Administration, as the company’s first humanitarian device....
May 04, 2023 04:15 pm ET
Globus Medical Reports First Quarter 2023 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2023. Worldwide net sales were $276.7 million, an increase of 20.0%, or 21.0% on a constant...
Apr 27, 2023 07:08 pm ET
Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that at the special meeting of shareholders held earlier today its shareholders voted to approve the issuance of shares of Globus Medical Class A common...
Apr 27, 2023 11:30 am ET
NuVasive Shareholders Approve Merger Agreement with Globus Medical
SAN DIEGO, April 27, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that at the special meeting of shareholders held earlier today, its shareholders voted to approve the adoption of the Company's merger agreement with Globus Medical (NYSE: GMED). As previously announced, under the terms of the merger agreement, NuVasive shareholders will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive comm
Apr 19, 2023 05:15 pm ET
Globus Medical Schedules First Quarter Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2023 after the market close on Thursday, May 4, 2023. A copy of the release will be available...
Apr 17, 2023 01:57 pm ET
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical
SAN DIEGO, April 17, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that proxy advisory firm, Glass Lewis & Co., LLC ("Glass Lewis"), recommends that NuVasive shareholders vote "FOR" the shareholder proposal to adopt the merger agreement with Globus Medical (NYSE: GMED) at NuVasive's upcoming special meeting of shareholders ("the special meeting") scheduled for April 27, 2023. Only holders of record of NuVasive common stock as
Apr 14, 2023 02:21 pm ET
Leading Independent Proxy Advisory Firm ISS Recommends NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical
SAN DIEGO, April 14, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that leading independent proxy advisory firm Institutional Shareholder Services ("ISS") recommends that NuVasive shareholders vote "FOR" the shareholder proposal to adopt the merger agreement with Globus Medical (NYSE: GMED) at NuVasive's upcoming special meeting of shareholders ("the special meeting") scheduled for April 27, 2023. Only holders of record of NuVasi
Apr 13, 2023 04:33 pm ET
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates TA, GMED, CBIO, AQUA
NEW YORK, April 13, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Mar 30, 2023 11:55 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMED, PRVB, INFI
NEW YORK, March 30, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Mar 26, 2023 10:01 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMED, ARGO, OSH
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Globus Medical, Inc. (NYSE: GMED)’s...
Mar 19, 2023 10:18 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, GMED, ARGO, OSH
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Focus Financial Partners Inc. (NASDAQ:...
Feb 21, 2023 04:15 pm ET
Globus Medical Reports Fourth Quarter and Full Year 2022 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2022. Fourth Quarter 2022: Worldwide net sales were $274.5 million, an...
Feb 12, 2023 08:49 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATCX, ALR, GMED
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Atlas Technical Consultants, Inc....
Feb 11, 2023 08:11 pm ET
Lifshitz Law PLLC Announces Investigations of SUMO, GMED, NUVA, and CSII
Sumo Logic, Inc. (NASDAQ: SUMO) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SUMO to affiliates of Francisco Partners for $12.05 per share in cash. If you are a SUMO...
Feb 10, 2023 10:17 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SUMO, NUVA, GMED
NEW YORK, Feb. 10, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Feb 09, 2023 06:01 pm ET
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of NuVasive, Inc.
NEW YORK, Feb. 9, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by NuVasive, Inc. (NASDAQ: NUVA) and its board of directors concerning the proposed acquisition of the company by Globus Medical, Inc. (NYSE: GMED). Stockholders will receive 0.75 shares of Globus Medical Class A common stock for each share of NuVasive, Inc. stock that they hold. The transaction is valued at approximately $3.1 billion and is expected to close in mid-2023.
Feb 09, 2023 08:11 am ET
GMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Globus Medical, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Globus Medical, Inc. (NYSE: GMED) and NuVasive, Inc. is fair to Globus shareholders. Under the terms of the merger agreement, NuVasive shareholders will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive common stock.
Feb 09, 2023 06:00 am ET
Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care
Capitalizes on complementary global commercial organizations and accelerates Globus Medical's and NuVasive's globalization strategies to increase customer reach and deepen surgeon relationships
Feb 02, 2023 04:30 pm ET
Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2022 after the market close on Tuesday, February 21, 2023. A copy of the...
Nov 08, 2022 04:15 pm ET
Globus Medical Reports Third Quarter 2022 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2022. Worldwide net sales were $254.1 million, an increase of 10.6%, or 12.6% on a constant...
Oct 19, 2022 04:30 pm ET
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2022 after the market close on Tuesday, November 8, 2022. A copy of the release will be...
Aug 04, 2022 04:15 pm ET
Globus Medical Reports Second Quarter 2022 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2022. Worldwide net sales were $263.6 million, an increase of 5.0% as reported, and an increase of...
Jul 18, 2022 04:30 pm ET
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2022 after the market close on Thursday, August 4, 2022. A copy of the release will be...
May 18, 2022 04:30 pm ET
Globus Medical Announces First Surgeries Using Excelsius3D™
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today the first surgeries performed with the Excelsius3D™, an intelligent, intraoperative 3-in-1 imaging platform, the latest addition to Globus Medical’s...
May 10, 2022 04:15 pm ET
Globus Medical Reports First Quarter 2022 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2022. Worldwide net sales were $230.5 million, an increase of 1.4% as...
Apr 21, 2022 04:17 pm ET
Globus Medical Schedules First Quarter Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2022 after the market close on Tuesday, May 10, 2022. A copy of the release will be available...
Apr 21, 2022 04:15 pm ET
Globus Medical Reports CEO Transition and Preliminary First Quarter 2022 Sales Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the resignation of President and Chief Executive Officer, Dave Demski, after nearly 20 years with the company, with the last four and a half years as...
Mar 04, 2022 04:57 pm ET
Globus Medical Announces the Expansion of its Share Repurchase Program
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has expanded the Company’s share repurchase program by authorizing the repurchase of an additional $200 million of the...
Feb 17, 2022 04:20 pm ET
Globus Medical Reports Fourth Quarter and Full Year 2021 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2021. Fourth Quarter 2021:...
Jan 27, 2022 04:30 pm ET
Globus Medical Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2021 after the market close on Thursday, February 17, 2022. A copy of the...
Nov 04, 2021 04:15 pm ET
Globus Medical Reports Third Quarter 2021 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2021. Worldwide net sales were $229.7 million, an increase of...
Oct 19, 2021 04:30 pm ET
Globus Medical Premieres ANTHEM® Mini Fragment Fracture System at Orthopaedic Trauma Association Meeting
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will feature its new ANTHEM® Mini Fragment Fracture System at the annual Orthopaedic Trauma Association (OTA) meeting in Fort Worth, Texas, Oct...
Oct 14, 2021 05:01 pm ET
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2021 after the market close on Thursday, November 4, 2021. A copy of the release will be...
Oct 13, 2021 04:30 pm ET
Globus Medical Files Suit Against Life Spine for IP Infringement
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today filed a lawsuit against Life Spine, Inc. alleging infringement of seven different patents related to Globus Medical’s expandable interbody spacer technology. This...
Sep 28, 2021 10:11 am ET
Globus Medical to Participate in North American Spine Society Annual Meeting
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will participate in the 36th Annual Meeting of the North American Spine Society (NASS) being held September 29 through October 2, 2021 at the Boston...
Sep 27, 2021 04:30 pm ET
Globus Medical Announces First ExcelsiusGPS® Cranial Surgery
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the first surgery performed with the ExcelsiusGPS® Cranial Solutions for robot-assisted navigated Deep Brain Stimulation (DBS). Cranial Solutions is the...
Aug 16, 2021 04:30 pm ET
Globus Medical Announces FDA 510(k) Clearance for Excelsius3D™
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that Excelsius3D™, an intelligent intraoperative 3-in-1 imaging system, has been granted 510(k) clearance by the U.S. Food and Drug Administration...
Aug 04, 2021 04:15 pm ET
Globus Medical Reports Second Quarter 2021 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2021. Worldwide net sales were $251.0 million, an increase of 68.6% as compared to the second...
Jul 16, 2021 08:30 am ET
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2021 after the market close on Wednesday, August 4, 2021. A copy of the release will be...
Jul 15, 2021 04:30 pm ET
Globus Medical Announces Completion of 20,000 Procedures Utilizing ExcelsiusGPS®
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that over 20,000 spine procedures have been performed utilizing the ExcelsiusGPS® Robotic Navigation system. “The ExcelsiusGPS® platform is one of the...
May 04, 2021 04:15 pm ET
Globus Medical Reports First Quarter 2021 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2021. Worldwide net sales were $227.3 million, an increase of 19.3% as compared to the first...
Apr 21, 2021 04:30 pm ET
Globus Medical Schedules First Quarter Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2021 after the market close on Tuesday, May 4, 2021. A copy of the release will be available on...
Apr 15, 2021 04:30 pm ET
Globus Medical Announces First Surgeries with Revolutionary CREO ONE™ Robotic Screw
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the recent launch of CREO ONE™, the market’s first robotic screw designed for spine surgery with ExcelsiusGPS®. CREO ONE™ enhances the...
Feb 17, 2021 04:15 pm ET
Globus Medical Reports Fourth Quarter and Full Year 2020 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2020. Fourth Quarter 2020: Worldwide net sales were $233.4 million, an...
Jan 28, 2021 04:30 pm ET
Globus Medical Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2020 after the market close on Wednesday, February 17, 2021. A copy of the...
Dec 09, 2020 04:30 pm ET
Globus Medical Trauma Division Awarded Purchasing Agreement with Premier Inc.
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, was recently awarded a group purchasing agreement with Premier, one of the largest group purchasing organizations in the United States. The agreement covers Globus’...
Nov 12, 2020 04:30 pm ET
Globus Medical Announces First Surgeries with ExcelsiusGPS® Interbody Solutions
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that Dr. Sheeraz Qureshi (Hospital for Special Surgery, New York, NY) and Dr. Paul Park (University of Michigan, Ann Arbor, MI) were the first surgeons...
Oct 28, 2020 04:15 pm ET
Globus Medical Reports Third Quarter 2020 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2020. Worldwide net sales were $216.1 million, an increase of 10.1% as compared to the third...
Oct 16, 2020 04:30 pm ET
Globus Medical Schedules Third Quarter 2020 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2020 after the market close on Wednesday, October 28, 2020. A copy of the release will be...
Oct 05, 2020 04:30 pm ET
Globus Medical to Participate as Platinum Sponsor at North American Spine Society Annual Meeting
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will participate as a platinum sponsor at the North American Spine Society (NASS) Annual Meeting and Virtual Experience hosted online from October...
Aug 07, 2020 09:31 am ET
Thinking about trading options or stock in Penn National Gaming, StoneCo Ltd, Facebook, Globus Medical, or Walt Disney?
NEW YORK, Aug. 7, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PENN, STNE, FB, GMED, and DIS.
Aug 05, 2020 04:15 pm ET
Globus Medical Reports Second Quarter 2020 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2020. Worldwide sales were $148.9 million, a decrease of 23.4% as reported Second quarter...
Jul 21, 2020 04:15 pm ET
Globus Medical Schedules Second Quarter 2020 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended June 30, 2020 after the market close on Wednesday, August 5, 2020. A copy of the release will be...
May 22, 2020 09:31 am ET
Thinking about trading stocks or options in Globus Medical, Alaska Air Group, Lululemon Athletica, Palo Alto Networks, or Carnival Corp?
NEW YORK, May 22, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GMED, ALK, LULU, PANW, and CCL.
May 07, 2020 04:15 pm ET
Globus Medical Reports First Quarter 2020 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2020. Worldwide sales were $190.6 million, an increase of 4.2% as reported First quarter...
Apr 16, 2020 04:30 pm ET
Globus Medical Schedules First Quarter 2020 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2020 after the market close on Thursday, May 7, 2020. A copy of the release will be available...
Mar 11, 2020 05:40 pm ET
Globus Medical Announces $200 Million Share Repurchase Program
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the Board of Directors authorized the repurchase of $200 million of the Company’s common stock. “We believe the recent stock market volatility has...
Feb 20, 2020 04:15 pm ET
Globus Medical Reports Fourth Quarter and Full Year 2019 Results
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2019. Fourth Quarter: Worldwide sales increased 8.0% as reported to $211.7...
Feb 06, 2020 04:30 pm ET
Globus Medical Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2019 after the market close on Thursday, February 20, 2020. A copy of the...
Feb 04, 2020 04:30 pm ET
Globus Medical Announces First Case with Next Generation 3D Printed Spine Implant
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company announced Dr. Joshua S. Rovner became the first spine surgeon to implant HEDRON IA, a 3D printed integrated ALIF spacer that leverages anchors or screws for vertebral...
Jan 08, 2020 04:30 pm ET
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2019. The company anticipates fourth quarter 2019 sales of...
Dec 13, 2019 04:15 pm ET
Globus Medical Announces Board of Director Addition and Departure
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the appointment of Robert Douglas to the Company’s Board of Directors, and the departure of Board member Kurt Wheeler, effective December 11, 2019.   Mr....
Nov 06, 2019 04:15 pm ET
Globus Medical Reports Third Quarter 2019 Results
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2019. Worldwide sales were $196.2 million, an increase of 15.9% as reported Third...
Oct 16, 2019 04:15 pm ET
Globus Medical Schedules Third Quarter 2019 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2019 after the market close on Wednesday, November 6, 2019. A copy of the release will be...
Sep 24, 2019 08:30 am ET
Globus Medical Launches AUTOBAHN® Intramedullary Nailing Platform at 2019 OTA Annual Meeting
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the launch of the AUTOBAHN® Nailing System. This comprehensive platform provides advanced clinical solutions for fractures of the tibia and femur....
Sep 19, 2019 04:15 pm ET
Globus Medical Showcases Latest Innovations at NASS 2019
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will highlight the company’s latest spinal implant and enabling technology innovations at the North American Spine Society (NASS) Annual Meeting held September 25-28,...
Aug 01, 2019 04:15 pm ET
Globus Medical Reports Second Quarter 2019 Results
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2019. Worldwide sales were $194.5 million, an increase of 12.2% as reported Second quarter...
Jul 15, 2019 08:00 am ET
Globus Medical Schedules Second Quarter 2019 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2019 after the market close on Thursday, August 1, 2019. A copy of the release will be...
Jun 27, 2019 04:30 pm ET
Globus Medical Appoints Keith Pfeil as Senior Vice President and CFO
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the appointment of Keith W. Pfeil as its Senior Vice President and Chief Financial Officer effective August 19, 2019. Mr. Pfeil joins Globus Medical...
May 30, 2019 04:15 pm ET
Globus Medical Launches First Expandable Interspinous Fixation – AERIAL™
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the launch of AERIAL™, a minimally invasive expandable interspinous fixation system with independent locking plates. The expandable central core of...
May 23, 2019 04:15 pm ET
New clinical data demonstrates the versatility of Globus Medical’s ExcelsiusGPS®
Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company today announced the results of a clinical study that evaluated the versatility of ExcelsiusGPS® Robotic navigation system compared to traditional pedicle screw placement...
May 02, 2019 04:15 pm ET
Globus Medical Reports First Quarter 2019 Results
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2019. Worldwide sales were $182.9 million, an increase of 4.9% as reportedFirst quarter net...
Apr 19, 2019 09:00 am ET
Detailed Research: Economic Perspectives on America First Multifamily Investors, Pluralsight, Globus Medical, ContraFect, Moleculin Biotech, and RumbleON — What Drives Growth in Today's Competitive La
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of America First Multifamily Investors, L.P. (NASDAQ:ATAX), Pluralsight, Inc....
Apr 17, 2019 05:01 pm ET
Globus Medical Schedules First Quarter 2019 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2019 after the market close on Thursday, May 2, 2019. A copy of the release will be available...
Apr 15, 2019 04:30 pm ET
Globus Medical Launches FORTIFY Variable Angle Expandable Corpectomy Spacer System
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the launch of FORTIFY VA™, a variable angle corpectomy solution, to add to its large and growing Expandable Technology portfolio.  Globus Medical is the...
Feb 21, 2019 04:15 pm ET
Globus Medical Reports Full Year and Fourth Quarter 2018 Results
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2018. Fourth Quarter: Worldwide sales increased 11.3% as reported to...
Feb 05, 2019 04:15 pm ET
Globus Medical Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2018 after the market close on Thursday, February 21, 2019. A copy of the...
Jan 30, 2019 08:15 am ET
Report: Developing Opportunities within Hyatt Hotels, Carter's, Globus Medical, Switch, Prothena Corporation plc, and Assurant — Future Expectations, Projections Moving into 2019
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Hyatt Hotels Corporation (NYSE:H), Carter's, Inc. (NYSE:CRI), Globus...
Jan 24, 2019 04:15 pm ET
Globus Medical’s SECURE®C Cervical Artificial Disc Receives Expanded Insurance Coverage
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, recently announced that the SECURE-C® Cervical Artificial Disc is now covered by Anthem, one of the largest health benefits companies in the United States with close to...
Jan 09, 2019 09:50 am ET
The Most Innovative Healthcare AI Developments of 2019
HOUSTON, TX / ACCESSWIRE / January 9, 2019 / Technology has changed in the blink of an eye.
Jan 08, 2019 04:15 pm ET
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2018. The company anticipates fourth quarter 2018 sales of...
Dec 06, 2018 04:30 pm ET
Globus Medical Enters International Market with ExcelsiusGPS® Robotic Guidance and Navigation System
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, recently announced the entrance of ExcelsiusGPS®, a revolutionary robotic guidance and navigation system, to the international market with system installations completed...
Nov 27, 2018 07:50 am ET
Report: Exploring Fundamental Drivers Behind Aclaris Therapeutics, Extreme Networks, Care, Air Lease, Globus Medical, and Heron Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aclaris Therapeutics, Inc. (NASDAQ:ACRS), Extreme Networks, Inc....
Nov 08, 2018 04:15 pm ET
Globus Medical Reports Third Quarter 2018 Results
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2018. Worldwide sales were $169.2 million, an increase of 11.5% as reportedThird quarter...
Oct 19, 2018 04:30 pm ET
Globus Medical Schedules Third Quarter 2018 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2018 after the market close on Thursday, November 8th, 2018. A copy of the release will be...
Oct 17, 2018 04:30 pm ET
Globus Medical Supporting Resident and Surgeon Education Workshops at OTA 2018
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today participation in Educational Workshops at the Orthopedic Trauma Association Annual Meeting October 17th- 20th in Orlando Florida. During the resident...
Oct 15, 2018 09:15 am ET
Consolidated Research: 2018 Summary Expectations for Atmos Energy, CatchMark Timber Trust, Globus Medical, HP, Marathon Oil, and Micron Technology — Fundamental Analysis, Key Performance Indications
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Atmos Energy Corporation (NYSE:ATO), CatchMark Timber Trust, Inc....
Oct 04, 2018 04:30 pm ET
Study Demonstrating Globus Medical’s Expandable Technology Improves Lordosis and Reduces Subsidence Awarded Best Paper at SMISS
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, announced today that a recent clinical study evaluating static versus expandable lateral lumbar interbody fusion devices was awarded best paper at the Society for...
Sep 25, 2018 05:37 pm ET
Globus Medical Sponsors NASS 2018, Hosts In-Booth Presentations on ExcelsiusGPS®
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will feature its ExcelsiusGPS® revolutionary robotic guidance and navigation system along with its latest advancements in expandable interbody technology at the North...
Sep 13, 2018 04:30 pm ET
Globus Medical Acquires Surgimap®
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the acquisition of Nemaris Inc., a privately held company that markets and develops Surgimap®, a leading surgical planning software platform. Surgimap®...
Aug 29, 2018 08:30 am ET
Globus Medical to Exhibit Latest Advancements in MIS Spine Surgery at SMISS Annual Forum
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will feature its ExcelsiusGPS® revolutionary robotic guidance and navigation system along with its latest advancements in expandable interbody technology at the Society...
Aug 14, 2018 08:25 am ET
New Research Coverage Highlights Arena Pharmaceuticals, Varian Medical, SS&C Technologies, Globus Medical, Zynga, and Diamondrock Hospitality — Consolidated Revenues, Company Growth, and Expectations
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Varian Medical Systems, Inc....
Aug 01, 2018 04:15 pm ET
Globus Medical Reports Second Quarter 2018 Results
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2018. Worldwide sales were $173.4 million, an increase of 13.8% as reportedSecond quarter...
Jul 16, 2018 04:15 pm ET
Globus Medical Schedules Second Quarter 2018 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2018 after the market close on Wednesday, August 1, 2018. A copy of the release will be...
Jul 11, 2018 11:15 am ET
Globus Medical Features Latest Innovative Technologies at Scoliosis Research Society’s International Meeting on Advanced Spine Technologies
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will showcase its advanced technologies at the Scoliosis Research Society’s (SRS) 25th Annual International Meeting on Advanced Spine Techniques (IMAST) being held July...
Jul 03, 2018 08:30 am ET
Globus Medical Adds Two Innovative Solutions to Growing Trauma Portfolio
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, announced today the expansion of its orthopedic trauma product portfolio with two new product offerings, the ANTHEM® Ankle Fracture System and the ANTHEM® Proximal...
Jun 26, 2018 04:15 pm ET
Globus Medical Announces ExcelsiusGPS® Milestone: 3,000 screws implanted
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, announced today a new clinical milestone with the successful implantation of over 3,000 screws using ExcelsiusGPS®,  the company’s revolutionary robotic guidance and...
Jun 13, 2018 04:15 pm ET
Globus Medical Launches Cement Augmented Pedicle Screw System
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the launch of the CREO® Fenestrated Screw System used in the treatment of patients with advanced stage tumors of the thoracolumbar spine. CREO®...
May 21, 2018 04:15 pm ET
Globus Medical Announces Appointment of Orthopedic Trauma Division’s Vice President of Sales
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the appointment of Daniel Gregoris to Vice President of Sales for the company’s emerging Orthopedic Trauma division.  Gregoris will be responsible for...
May 15, 2018 04:15 pm ET
Globus Medical Announces Positive Clinical Results for Lateral Expandable Technology
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the results of the study “Clinical and radiographic analysis of expandable versus static lateral lumbar interbody fusion devices with two-year follow-up”...
May 10, 2018 04:15 pm ET
Globus Medical Announces Corporate Alliance Partnership with the Society of Lateral Access Surgery
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, announced today it is sponsoring the Society of Lateral Access Surgery’s (SOLAS®) newly developed Partnership Program as that organization’s first corporate Alliance...
May 02, 2018 04:15 pm ET
Globus Medical Reports First Quarter 2018 Results
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2018. Worldwide sales were $174.4 million, an increase of 11.9% as reported, or 10.8% in...
Apr 20, 2018 08:20 am ET
Market Trends Toward New Normal in Jones Energy, Sunrun, Toll Brothers, Myriad Genetics, Globus Medical, and Asure Software — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, April 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Jones Energy, Inc. (NYSE:JONE), Sunrun Inc....
Apr 17, 2018 04:24 pm ET
Globus Medical Schedules First Quarter 2018 Earnings Release and Conference Call
AUDUBON, Penn., April 17, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2018 after the market close on Wednesday, May 2, 2018....
Apr 05, 2018 04:15 pm ET
Globus Medical Announces Launch of ELSA® Expandable Lateral Spacer System
AUDUBON, Pa., April 05, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the launch of two innovative lateral expandable interbody spacers with integrated screw fixation, ELSA® AL and ELSA®-ATP, the latest...
Mar 06, 2018 04:15 pm ET
Globus Medical Enters Trauma Market
To Showcase Portfolio of Orthopedic Trauma Products at AAOS
Feb 21, 2018 04:15 pm ET
Globus Medical Reports Full Year and Fourth Quarter 2017 Results
AUDUBON, Pa., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2017.
Feb 21, 2018 12:15 pm ET
Globus Medical, Inc. Class A to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 21, 2018 / Globus Medical, Inc. Class A (NYSE: GMED) will be discussing their earnings results in their Q4 Earnings Call to be held on February 21, 2018, at 4:30 PM Eastern Time.
Feb 15, 2018 07:30 am ET
Research Report Identifies Umpqua, Westrock, Globus Medical, Procter & Gamble, ACADIA Pharmaceuticals, and Cree with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, Feb. 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Umpqua Holdings Corporation (NASDAQ:UMPQ), Westrock Company...
Feb 09, 2018 08:30 am ET
Globus Medical Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call
AUDUBON, Pa., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2017 after the market close on...
Jan 09, 2018 08:30 am ET
Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results
AUDUBON, Pa., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2017. The company anticipates fourth...
Nov 30, 2017 07:30 pm ET
Globus Medical Announces Clinical Results Showing Superiority of its SECURE-C® to ACDF at Seven Years
SECURE-C® long-term data confirms earlier clinical outcomes and maintains superiority
Nov 30, 2017 08:10 am ET
Report: Developing Opportunities within Procter & Gamble, ACADIA Pharmaceuticals, Cree, Umpqua, Westrock, and Globus Medical — Future Expectations, Projections Moving into 2018
NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Procter & Gamble Company (NYSE:PG),...
Nov 20, 2017 04:15 pm ET
Globus Medical to Participate in the Piper Jaffray 29th Annual Healthcare Conference
AUDUBON, Pa., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that management plans to participate in the Piper Jaffray 29th Annual Healthcare Conference at the Lotte New York Palace...
Nov 08, 2017 04:30 pm ET
Globus Medical Reports Third Quarter 2017 Results
AUDUBON, Pa., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2017.
Oct 17, 2017 04:30 pm ET
Globus Medical Schedules Third Quarter 2017 Earnings Release and Conference Call
AUDUBON, Pa., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2017 after the market close on Wednesday, November 8, 2017. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors....
Oct 10, 2017 04:30 pm ET
Globus Medical Announces First Spine Surgeries Using ExcelsiusGPS™
AUDUBON, Pa., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the first spine surgeries using ExcelsiusGPS™, a revolutionary robotic guidance and navigation system. Surgeries using ExcelsiusGPS™ were performed last week at The Johns Hopkins Hospital in Baltimore, Maryland and St. Mark’s Hospital in Salt Lake City, Utah.  The surgical team at Johns Hopkins was led by neurosurgeons Dr. Nick Theodore and Dr. Ali Bydon, while orthopedic spine surgeon Dr. Kade Huntsman performed the surgeries at St. Marks....
Aug 29, 2017 04:15 pm ET
Globus Medical Appoints David M. Demski as CEO
AUDUBON, Penn., Aug. 29, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that, the Board of Directors has named David M. Demski as the Company’s Chief Executive Officer, effective immediately.  Mr. Demski will report to David C. Paul, the Company’s founder, Chairman of the Board, and Chief Executive Officer since its inception in 2003.  Mr. Paul will remain in the role of Executive Chairman. ...
Aug 02, 2017 04:30 pm ET
Globus Medical Announces Acquisition of Robotics Developer KB Medical
AUDUBON, Pa., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions manufacturer, today announced that the acquisition of KB Medical, SA, a robotic developer based in Lausanne, Switzerland, closed during the second quarter of 2017....
Aug 02, 2017 04:30 pm ET
Globus Medical Reports Second Quarter 2017 Results
AUDUBON, Pa., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions manufacturer, today announced its financial results for the second quarter ended June 30, 2017....
Jul 10, 2017 06:41 pm ET
Globus Medical Schedules Second Quarter 2017 Earnings Release and Conference Call
AUDUBON, Pa., July 10, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the second quarter ended June 30, 2017 after the market close on Wednesday, August 2, 2017. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors....
May 03, 2017 04:15 pm ET
Globus Medical Reports First Quarter 2017 Results
AUDUBON, Pa., May 03, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2017....
Apr 17, 2017 04:15 pm ET
Globus Medical Schedules First Quarter 2017 Earnings Release and Conference Call
AUDUBON, Pa., April 17, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the first quarter ended March 31, 2017 after the market close on Wednesday, May 3, 2017. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors....
Feb 27, 2017 04:40 pm ET
Globus Medical Reports Full Year and Fourth Quarter 2016 Results
AUDUBON, Pa., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the fourth quarter and year ended December 31, 2016....
Feb 09, 2017 04:15 pm ET
Globus Medical to Present at Leerink Partners 6th Annual Global Healthcare Conference 2017
AUDUBON, Pa., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that management will present at the Leerink Partners 6th Annual Global Healthcare Conference at the Lotte New York Palace Hotel in New York, New York on Wednesday, February 15, 2017 at 9:30 a.m. ET....
Feb 07, 2017 04:15 pm ET
Globus Medical Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call
AUDUBON, Pa., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the fourth quarter and full year ended December 31, 2016 after the market close on Monday, February 27, 2017. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors....
Jan 10, 2017 05:07 pm ET
Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results
AUDUBON, Pa., Jan. 10, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2016. The company anticipates fourth quarter 2016 sales of approximately $151.6 million, an increase of 6.3% as reported or 6.6% in constant currency over the fourth quarter 2015. Full year 2016 estimated sales are expected to be approximately $564.0 million, an increase of 3.5% as reported or 3.8% in constant currency over the prior year....
Jan 05, 2017 04:15 pm ET
Globus Medical Announces CE Mark for Excelsius GPS™
AUDUBON, Pa., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that the Excelsius GPS™, a revolutionary system providing robotic trajectory guidance and navigation, is now CE marked. This platform technology supports both minimally invasive and open orthopedic and neurosurgical procedures, with applications ranging from the cervical spine to the sacroilium, long bones and cranium. Excelsius GPS™ seamlessly integrates with Globus Medical implants and instruments and is compatible with pre-operative CT, intra-...
Dec 02, 2016 06:02 pm ET
Globus Medical and UMB Financial Set to Join S&P MidCap 400; HomeStreet to Join S&P SmallCap 600
NEW YORK, Dec. 2, 2016 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 after the close of trading on Tuesday, December 6:
Nov 08, 2016 04:15 pm ET
Globus Medical Reports Third Quarter 2016 Results
AUDUBON, Pa., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter ended September 30, 2016....
Oct 25, 2016 04:15 pm ET
Globus Medical Launches INDEPENDENCE MIS™, a Minimally Invasive ALIF Integrated Plate-Spacer
AUDUBON, Pa., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced the introduction of the INDEPENDENCE MIS™ System, an integrated ALIF plate-spacer system designed to simplify implantation and fixation of a commonly challenging procedure....
Oct 25, 2016 04:15 pm ET
Globus Medical Launches QUARTEX™ OCT Stabilization System
AUDUBON, Pa., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, continues to innovate in the treatment of complex spinal instability and deformity with today’s announcement of the launch of the QUARTEX™ OCT Stabilization System....
Oct 19, 2016 06:53 pm ET
Globus Medical Schedules Third Quarter 2016 Earnings Release and Conference Call
AUDUBON, Pa., Oct. 19, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the third quarter ended September 30, 2016, after the market close on Tuesday, November 8, 2016. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors....
Sep 01, 2016 04:22 pm ET
Alphatec Holdings Completes Sale of International Business to Globus Medical
CARLSBAD, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, today announced the completion of the previously announced sale of its international operations and distribution channel to Globus Medical (NYSE:GMED), a leading musculoskeletal implant manufacturer....
Sep 01, 2016 04:15 pm ET
Globus Medical Completes Acquisition of Alphatec’s International Business
AUDUBON, Pa., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that it has successfully completed the previously announced acquisition of the international operations and distribution channels of Alphatec Holdings, Inc., a publicly traded medical devices company (Nasdaq:ATEC)....
Jul 26, 2016 04:30 pm ET
Alphatec Holdings Announces Sale of International Business to Globus Medical
CARLSBAD, Calif., July 26, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that it has entered into a definitive agreement with Globus Medical (NYSE:GMED), a leading musculoskeletal implant manufacturer, whereby Globus will acquire Alphatec’s international operations and distribution channel for a purchase price of $80 million. As part of the transaction, Globus has also agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million. ...
Jul 26, 2016 04:30 pm ET
Globus Medical Announces the Acquisition of Alphatec’s International Business
AUDUBON, Pa., July 26, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that it has entered into an agreement to acquire the international operations and distribution channels of Alphatec Holdings, Inc., a publicly traded medical devices company (Nasdaq:ATEC) for $80.0 million in cash, subject to certain closing adjustments. Globus Medical also agreed to extend a 5-year senior secured credit facility of up to $30.0 million to Alphatec to support their working capital needs. The parties expect the closing of the acqui...
Jul 26, 2016 04:30 pm ET
Globus Medical Reports Second Quarter 2016 Results
AUDUBON, Pa., July 26, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter ended June 30, 2016....
Jul 15, 2016 12:41 pm ET
Globus Medical Schedules Second Quarter 2016 Earnings Release and Conference Call
AUDUBON, Pa., July 15, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the second quarter ended June 30, 2016 after the market close on Tuesday, July 26, 2016. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors....
May 10, 2016 04:15 pm ET
Globus Medical Appoints Eric Ian Schwartz as Senior Vice President and General Counsel
AUDUBON, Pa., May 10, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced it appointed Eric Ian Schwartz as its Senior Vice President and General Counsel effective April 28, 2016....
May 03, 2016 04:15 pm ET
Globus Medical Reports First Quarter 2016 Results
AUDUBON, Pa., May 03, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2016....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.